In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...

In the new SCALE Kids study, which has been published in the New England Journal of Medicine, a daily 3mg dose of Saxenda reduced the body mass index (BMI) of the children by an average of 5.8% ...

CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) and Johns Hopkins University have successfully submitted our proposal for a NIH Grant that will utilize CTT's patented technology as a smoking cessation ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Saxenda is the brand name of liraglutide 3 mg ... This drug has FDA approval in a low dose and for short-term use for treating obesity. Optum Perks offers Adepix-P for delivery to a range of ...

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

The typical starting dosage ranges from 10 to 60 milligrams (mg) daily. Your doctor may adjust your dosage over the course of your treatment. The active ingredient in Prozac is fluoxetine.